AND-017

N/A

Report date: 2026/03/30 20:02:02
NME

Base Information

Drug NameAND-017
Drug Alias NameAND-017
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHypoxia-inducible factor prolyl hydroxylase inhibitors
TargetsHypoxia-inducible factor prolyl hydroxylase
Therapy Area/IndicationsMyelodysplastic Syndromesbeta-ThalassemiaAnemia +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Inactive CompaniesN/A
Active IndicationsMyelodysplastic Syndromesbeta-ThalassemiaAnemia +[4
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A